Tokyo, Aug. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058777) titled 'Determining the Optimal Number of Specimens for FISH Analysis in Gastrointestinal Mucosa' on Aug. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University Hospital
Condition:
Condition - Gastrointestinal lymphoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Fluorescence in situ hybridization (FISH) plays an important role in the diagnosis of gastrointestinal lymphomas. Typically, five endoscopic biopsy specimens are collected for FISH analysis; however, the optimal number of biopsy specimens required for sufficient FISH testing has not been investigated. This study aims to establish the optimal submission method for FISH specimens from gastrointestinal mucosa.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients with gastrointestinal lymphoma scheduled for endoscopy and biopsy
Key exclusion criteria - Women who are pregnant or may be pregnant
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 03 Month 07 Day
Date of IRB - 2025 Year 03 Month 07 Day
Anticipated trial start date - 2025 Year 03 Month 07 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067209
Disclaimer: Curated by HT Syndication.
